X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (102) 102
cardiac & cardiovascular systems (78) 78
male (56) 56
female (52) 52
middle aged (48) 48
index medicus (40) 40
percutaneous coronary intervention (39) 39
aged (37) 37
acute myocardial-infarction (33) 33
intracoronary verapamil (33) 33
treatment outcome (30) 30
angioplasty (28) 28
coronary angiography (27) 27
no-reflow (26) 26
intracoronary adenosine (25) 25
adenosine (22) 22
myocardial infarction - therapy (22) 22
reperfusion (22) 22
animals (21) 21
cardiology (21) 21
no-reflow phenomenon (21) 21
pharmacology & pharmacy (21) 21
primary angioplasty (21) 21
angioplasty, balloon, coronary (20) 20
microvascular obstruction (20) 20
verapamil (20) 20
electrocardiography (19) 19
calcium channel blockers - therapeutic use (18) 18
myocardial infarction - physiopathology (18) 18
vasodilator agents - therapeutic use (18) 18
coronary vessels (17) 17
coronary circulation (16) 16
coronary circulation - drug effects (16) 16
heart attacks (16) 16
myocardial infarction (16) 16
reperfusion injury (16) 16
adenosine - therapeutic use (15) 15
blood-flow (15) 15
vasodilator agents - administration & dosage (15) 15
follow-up studies (14) 14
left-ventricular function (14) 14
therapy (14) 14
cardiovascular system (13) 13
heart attack (13) 13
prospective studies (13) 13
transluminal angioplasty (13) 13
verapamil - therapeutic use (13) 13
cardiovascular (12) 12
microcirculation (12) 12
stents (12) 12
care and treatment (11) 11
contrast echocardiography (11) 11
coronary vessels - physiopathology (11) 11
flow (11) 11
medicine & public health (11) 11
myocardial infarction - mortality (11) 11
nitroglycerin (11) 11
artery (10) 10
calcium channel blockers - administration & dosage (10) 10
cardiac patients (10) 10
cardiovascular diseases (10) 10
coronary vessels - drug effects (10) 10
diltiazem (10) 10
ischemia (10) 10
myocardial reperfusion (10) 10
nifedipine (10) 10
percutaneous coronary intervention - methods (10) 10
verapamil - administration & dosage (10) 10
acute myocardial infarction (9) 9
adenosine - administration & dosage (9) 9
angioplasty, balloon, coronary - adverse effects (9) 9
balloon angioplasty (9) 9
coronary artery bypass (9) 9
myocardial reperfusion injury - prevention & control (9) 9
retrospective studies (9) 9
time factors (9) 9
adult (8) 8
blood pressure - drug effects (8) 8
coronary circulation - physiology (8) 8
distal embolization (8) 8
myocardial infarction - drug therapy (8) 8
myocardial infarction - surgery (8) 8
nicorandil (8) 8
peripheral vascular disease (8) 8
size (8) 8
thrombus aspiration (8) 8
timi frame count (8) 8
trial (8) 8
analysis (7) 7
coronary heart disease (7) 7
dosage and administration (7) 7
heart (7) 7
infarct size (7) 7
injections, intra-arterial (7) 7
intracoronary (7) 7
medicine, general & internal (7) 7
mortality (7) 7
myocardial infarction - diagnosis (7) 7
myocardial ischemia (7) 7
myocardial ischemia - physiopathology (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 11/2010, Volume 76, Issue 6, pp. 787 - 793
Background: No previous study has assessed the possible role of dipyridamole for treatment of no‐reflow during acute myocardial infarction (AMI). Methods and... 
adenosine | vasodilation | vasoconstriction | no‐reflow | acute myocardial infarction | trial | angioplasty | no-reflow | INTRACORONARY VERAPAMIL | CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTOR | EFFICACY | ANTIOXIDANT DRUG DIPYRIDAMOLE | PERCUTANEOUS CORONARY INTERVENTION | ACUTE MYOCARDIAL-INFARCTION | Single-Blind Method | Myocardial Infarction - mortality | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Vasodilator Agents - therapeutic use | Humans | Middle Aged | No-Reflow Phenomenon - mortality | Male | Myocardial Infarction - diagnostic imaging | Verapamil - administration & dosage | Myocardial Perfusion Imaging | Angioplasty, Balloon, Coronary - adverse effects | Myocardial Infarction - therapy | Verapamil - therapeutic use | Angioplasty, Balloon, Coronary - mortality | Time Factors | Verapamil - adverse effects | Dipyridamole - adverse effects | No-Reflow Phenomenon - etiology | Female | Myocardial Infarction - physiopathology | No-Reflow Phenomenon - diagnostic imaging | No-Reflow Phenomenon - physiopathology | Dipyridamole - therapeutic use | Stents | Infusions, Parenteral | Treatment Outcome | Chi-Square Distribution | No-Reflow Phenomenon - drug therapy | Coronary Angiography | Italy | Aged | Coronary Circulation - drug effects | Dipyridamole - administration & dosage | Vasodilator Agents - adverse effects | Drug Substitution | Vasodilator Agents - administration & dosage
Journal Article
Journal Article
JOURNAL OF NEUROSURGERY, ISSN 0022-3085, 10/2010, Volume 113, Issue 4, pp. 913 - 922
Object. Vasospasm is one of the leading causes of morbidity and death following aneurysmal subarachnoid hemorrhage (SAH). Many patients suffer devastating... 
SURGERY | INTRACORONARY VERAPAMIL | CONTROLLED TRIAL | ANEURYSMAL SUBARACHNOID HEMORRHAGE | INTRACRANIAL-PRESSURE CHANGES | verapamil | CALCIUM-ANTAGONISTS | NIMODIPINE | cerebral vasospasm | endovascular therapy | CLINICAL NEUROLOGY | PENETRATING ARTERIOLES | BALLOON ANGIOPLASTY | CEREBRAL-BLOOD-FLOW | CORONARY-ARTERY SPASM
Journal Article
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2012, Volume 164, Issue 3, pp. 394 - 401
Journal Article
Journal Article
Journal Article